Pharmacy-based Pre-exposure Prophylaxis

NACompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

May 19, 2022

Primary Completion Date

May 11, 2024

Study Completion Date

May 11, 2024

Conditions
Human Immunodeficiency Virus
Interventions
BEHAVIORAL

Pharmacy Delivered PrEP Intervention

Pharmacy client participants who are eligible and agree to the HIV test will be provided with a pre-packaged kit of a self-administered test for HIV and directed back to the private area of the pharmacy to perform their screening. Pharmacy client participants who test HIV negative will be provided with their results and be given a 30-day prescription for PrEP, culturally appropriate PrEP counseling and a follow-up appointment with a PrEP prescribing physician. Pharmacy client participants will be contacted after 3 months to determine whether they continued PrEP use.

Trial Locations (1)

30322

Emory University, Atlanta

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Emory University

OTHER